首页 | 本学科首页   官方微博 | 高级检索  
     

多孔微晶玻璃作为药物载体材料的制备及其体外释药研究
引用本文:王德平,黄文显,陈天丹.多孔微晶玻璃作为药物载体材料的制备及其体外释药研究[J].无机材料学报,2001,16(6):1195-1198.
作者姓名:王德平  黄文显  陈天丹
作者单位:同济大学材料科学与工程学院,
摘    要:应用玻璃结晶法制备了以磷酸钙为主体的多孔微晶玻璃载体材料,并以利福平作为模型药物进行了体外释药试验。研究表明该载体材料能够在高浓度水平下长期维持药物的稳定释放;研究结果还显示调节磷酸钙纤维的几何尺寸可以有效地改变载体材料的空隙率,因此有望成为一种理想的DDS(Drug delivery system)药物控释性释放的新型无机载体材料。

关 键 词:生物微晶玻璃  药物载体  缓释作用  药物  控释性释放  制备  显微结构  体外释药
文章编号:1000-324(2001)06-1195-04
收稿时间:2000-12-4
修稿时间:2000年12月4日

Preparation and in Vitro Drug Release Behavior Study of Porous Phosphate Glass Ceramic
WANG De-Ping,HUANG Wen-Hai,CHENG Tian-Dan.Preparation and in Vitro Drug Release Behavior Study of Porous Phosphate Glass Ceramic[J].Journal of Inorganic Materials,2001,16(6):1195-1198.
Authors:WANG De-Ping  HUANG Wen-Hai  CHENG Tian-Dan
Affiliation:SchoolofMaterialsScienceandEngineering;TongjiUniversity;Shanghai200092;China
Abstract:The preparation and properties of porous glass ceramic (PGC) carrier materials made from the base glass composition CaO-P2O5 were investigated. Rifapin (R) was used as a model drug, in vitro drug delivery anylyses of R-PGC were performed. Based on this results, the drug carrier can gradually re1ease rifapin with effective drug concentration in 1ong time. Through the adjustment of aspect ratios of calcium phosphate fiber, the porosity can be effeictely changed. So it is helpful to make the durg delivery system (DDS), and further study should be engaged.
Keywords:bioglass ceramic  drug carrier  slow-release
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《无机材料学报》浏览原始摘要信息
点击此处可从《无机材料学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号